Ubiquinol-cytochrome c reductase complex 6.7 kDa Antibody
Description
Overview of Ubiquinol-Cytochrome c Reductase Complex kDa Antibody
The Ubiquinol-cytochrome c reductase complex 6.7 kDa antibody is a polyclonal antibody targeting the 6.7 kDa subunit of mitochondrial complex III (cytochrome b-c1 complex), a critical component of the electron transport chain (ETC) responsible for oxidative phosphorylation . This subunit plays a structural and functional role in stabilizing the complex and facilitating electron transfer from ubiquinol to cytochrome c, coupled with proton translocation across the mitochondrial inner membrane .
4.1. Mitochondrial Dysfunction Studies
-
Complex III dysfunction, detectable via 6.7 kDa antibody-based assays, is linked to impaired electron transport in ischemia-reperfusion injury .
-
Downregulation of ETC subunits like the 6.7 kDa protein correlates with neurodegenerative diseases and metabolic disorders .
4.2. Technical Performance
-
Western Blot: Detects a ~6.7 kDa band in mitochondrial lysates (species-specific validation required) .
-
ELISA: Quantifies subunit expression levels under oxidative stress conditions .
Comparative Analysis of Complex III Antibodies
While the 6.7 kDa antibody is specific to a small subunit, other antibodies target larger core proteins (e.g., UQCRC1 at 53 kDa).
Table 3: Complex III Subunit Antibodies
Challenges and Limitations
-
Species Specificity: The 6.7 kDa antibody described in is validated for potato; human homologs may require distinct antibodies (e.g., UQCR10 or UQCRQ) .
-
Low Protein Abundance: The small size and low abundance of the 6.7 kDa subunit necessitate high-sensitivity detection methods .
Future Directions
Product Specs
Target Background
Q&A
What is the role of the ubiquinol-cytochrome c reductase complex in the mitochondrial respiratory chain?
Ubiquinol-cytochrome c reductase (also known as cytochrome bc1 or complex III) is a crucial component of the mitochondrial respiratory (electron transport) chain. This protein complex mediates electron transfer from ubiquinol to cytochrome c, which significantly contributes to the generation of a proton gradient that powers ATP synthesis. The 6.7 kDa subunit is one of the integral membrane proteins within this complex, which collectively facilitate efficient electron transfer across the inner mitochondrial membrane. Complex III plays a central role in cellular bioenergetics by coupling electron movement to proton translocation, thus maintaining the electrochemical gradient necessary for oxidative phosphorylation .
What are the recommended applications for ubiquinol-cytochrome c reductase complex antibodies?
Based on research patterns with similar mitochondrial complex antibodies, the primary applications include:
| Application | Typical Dilution | Sample Type | Expected Results |
|---|---|---|---|
| Western Blotting | 1:1000 | Tissue/cell lysates | Detection of target protein band at ~6.7 kDa |
| Immunoprecipitation | 1:50 | Solubilized membrane fractions | Enrichment of target protein and associated complex members |
| Immunohistochemistry | 1:100-1:500 | Fixed tissue sections | Mitochondrial localization pattern |
| Immunofluorescence | 1:200 | Fixed cells | Mitochondrial network visualization |
These applications allow researchers to study the expression, localization, and interactions of the complex subunit in various experimental contexts .
How should samples be prepared for optimal detection of ubiquinol-cytochrome c reductase components?
For optimal detection of mitochondrial membrane proteins like the ubiquinol-cytochrome c reductase complex components, sample preparation is critical. Mitochondrial enrichment protocols are recommended prior to antibody-based detection. This typically involves tissue or cell homogenization in an isotonic buffer followed by differential centrifugation to isolate the mitochondrial fraction. For membrane protein extraction, non-denaturing detergents (such as digitonin or n-dodecyl β-D-maltoside) at carefully optimized concentrations are preferable to maintain the native structure of membrane protein complexes. When preparing submitochondrial particles for functional studies, sonication of mitochondria followed by centrifugation can generate inside-out vesicles that expose the electron transport chain components .
How can cytochrome c be used to monitor electron transport inhibition in research utilizing the ubiquinol-cytochrome c reductase complex?
Cytochrome c serves as an excellent indicator for monitoring electron transport and its inhibition in experimental systems involving the ubiquinol-cytochrome c reductase complex. The reduction of cytochrome c can be monitored spectrophotometrically at 550 nm, providing a direct measurement of electron transport activity. This method offers advantages over traditional redox-active dyes like DCPIP because it allows researchers to observe the effects of specific respiratory inhibitors such as antimycin A (which blocks electron transfer from cytochrome b to cytochrome c1) and rotenone (which inhibits complex I).
The experimental setup typically involves:
-
Preparation of submitochondrial particles (SMPs) from bovine heart or other tissue sources
-
Addition of specific electron donors (NADH or succinate)
-
Monitoring cytochrome c reduction at 550 nm
-
Introduction of inhibitors to assess their impact on the electron transport rate
This approach provides valuable insights into both the normal function of the ubiquinol-cytochrome c reductase complex and how various compounds might disrupt its activity in pathological conditions .
What are the common issues encountered when using antibodies against small subunits of the ubiquinol-cytochrome c reductase complex, and how can they be resolved?
When working with antibodies against small subunits like the 6.7 kDa component of the ubiquinol-cytochrome c reductase complex, researchers commonly encounter several challenges:
| Challenge | Solution | Rationale |
|---|---|---|
| Poor signal intensity | Optimize protein loading (15-30 μg); Use enhanced detection systems | Small proteins transfer efficiently but may be present in lower abundance |
| Nonspecific binding | Increase blocking time; Use 5% BSA instead of milk for blocking | Prevents antibody binding to non-target proteins |
| Protein loss during transfer | Use PVDF membranes with 0.2 μm pore size; Adjust transfer conditions | Small proteins can pass through larger pore membranes |
| Cross-reactivity with other complex subunits | Perform antibody validation with purified proteins | Confirms specificity for the target subunit |
| Degradation during sample preparation | Add protease inhibitors; Keep samples cold; Process quickly | Prevents enzymatic degradation of small proteins |
These optimization strategies can significantly improve the quality and reliability of experimental results when working with antibodies against small mitochondrial complex subunits .
How do mutations in the MT-CYB gene affect the detection and function of ubiquinol-cytochrome c reductase complex in research models?
Mutations in the MT-CYB gene, which encodes cytochrome b (a key component of the ubiquinol-cytochrome c reductase complex), can significantly impact both the detection and functional analysis of the complex in research models. These mutations may alter epitope accessibility, protein stability, complex assembly, and electron transport activity.
From a detection perspective, researchers should consider:
-
Using multiple antibodies targeting different regions of the complex
-
Comparing antibody binding patterns between wild-type and mutant samples
-
Correlating antibody detection with functional assays
-
Employing mass spectrometry for unbiased protein identification
Functionally, MT-CYB mutations have been linked to various pathologies, making them valuable research targets. When studying these mutations, researchers should monitor both protein expression and electron transport activity. The cytochrome c reduction assay described earlier can provide crucial information about how specific mutations affect the electron transfer capabilities of the complex. Additionally, combining immunological detection with functional assays creates a more comprehensive understanding of how mutations impact both the structure and function of the ubiquinol-cytochrome c reductase complex .
What considerations should researchers make when selecting antibodies for studying specific subunits of the ubiquinol-cytochrome c reductase complex?
When selecting antibodies for studying specific subunits of the ubiquinol-cytochrome c reductase complex, researchers should consider multiple factors to ensure experimental success:
| Selection Criteria | Importance | Implementation |
|---|---|---|
| Species reactivity | Ensures compatibility with research model | Select antibodies tested against target species (e.g., Human, Mouse) |
| Epitope location | Affects accessibility in native vs. denatured states | Choose antibodies with epitopes suitable for intended application |
| Validation data | Confirms specificity and performance | Review supporting data (Western blots, IP results) provided by manufacturers |
| Clonality | Impacts specificity and batch consistency | Monoclonal for specific epitopes; polyclonal for broader detection |
| Cross-reactivity profile | Prevents false positives | Check tested reactivity against related proteins |
| Application suitability | Ensures performance in intended experiments | Verify antibody has been validated for specific techniques (WB, IP, IHC) |
For small subunits like the 6.7 kDa component, additional verification may be necessary as these can be more challenging to detect reliably. Researchers should consider performing their own validation experiments, including positive and negative controls, before proceeding with critical experiments .
How can advanced antibody development platforms be utilized for creating more specific antibodies against ubiquinol-cytochrome c reductase complex components?
Modern antibody development platforms offer significant advantages for creating highly specific antibodies against challenging targets like the ubiquinol-cytochrome c reductase complex components. Technologies like Cyagen's HUGO-Ab™ platform utilize fully humanized mice engineered to produce human monoclonal antibodies with improved specificity and reduced immunogenicity.
For developing antibodies against mitochondrial complex components:
-
Transgenic mice systems provide a humanized immune system context, allowing antibodies to undergo natural immune diversification and selection similar to processes in the human body. This results in antibodies with high affinity and specificity for the target protein.
-
Precise gene editing technologies like TurboKnockout® enable accurate modifications for constructing complex genetic models, which can be valuable when studying the impact of specific mutations on antibody binding and complex function.
-
High-throughput screening platforms like AbDrop™ use microfluidic technology to isolate and screen single B cells efficiently. This approach allows researchers to capture diverse antibody sequences from individual cells, significantly speeding up the discovery of antibodies with optimal binding characteristics to specific complex subunits.
These advanced technologies can help overcome challenges associated with developing antibodies against small or highly conserved subunits of multi-protein complexes like the ubiquinol-cytochrome c reductase complex .
How do researchers distinguish between different autoantibody profiles when studying mitochondrial complexes in autoimmune diseases?
When investigating potential autoimmune responses against mitochondrial complexes like the ubiquinol-cytochrome c reductase complex, researchers must employ careful approaches to distinguish between different autoantibody profiles. This is particularly important as autoantibodies may target various components of the respiratory chain complexes.
Based on methodologies employed for other autoantibody systems, the following approach is recommended:
| Step | Methodology | Purpose |
|---|---|---|
| Separate antibody detection | Test for antibodies against individual subunits separately | Prevents masking of specific reactivity patterns |
| Cross-absorption studies | Pre-absorb sera with purified antigens | Demonstrates specificity of antibody binding |
| Epitope mapping | Use overlapping peptides covering target proteins | Identifies specific binding regions |
| Clinical correlation | Compare antibody profiles with disease manifestations | Establishes clinical relevance of findings |
Studies of autoantibody systems like anti-Ro52/anti-Ro60 have demonstrated that distinct autoantibody profiles can be associated with different disease manifestations, severity, and treatment responses. For example, in a study of various autoimmune diseases, different patterns of anti-Ro antibodies were associated with specific clinical presentations in conditions like Sjögren's syndrome, systemic lupus, systemic sclerosis, and inflammatory myositis .
What methods can researchers use to study the electron transport function of ubiquinol-cytochrome c reductase complex in different pathological states?
Researchers can employ several sophisticated methods to study the electron transport function of the ubiquinol-cytochrome c reductase complex in various pathological states:
These functional assays provide valuable insights into how pathological states affect not just the presence but also the activity of the ubiquinol-cytochrome c reductase complex .
How can researchers correlate mutations in MT-CYB with changes in ubiquinol-cytochrome c reductase complex activity in disease studies?
Correlating MT-CYB mutations with functional changes in the ubiquinol-cytochrome c reductase complex requires an integrated approach combining genetic, structural, and functional analyses:
-
Genetic analysis: Sequencing of the mitochondrial genome to identify specific mutations in MT-CYB from patient samples or disease models. Next-generation sequencing allows detection of heteroplasmy (mixture of mutant and wild-type mitochondrial DNA) with high sensitivity.
-
Protein expression and complex assembly: Western blotting with antibodies against various components of the complex can reveal changes in protein levels or altered migration patterns indicating assembly defects. Blue Native PAGE can visualize intact or partially assembled complexes.
-
Structural analysis: Cryo-electron microscopy or X-ray crystallography can provide insights into how specific mutations alter the three-dimensional structure of the complex, potentially explaining functional defects.
-
Functional assessment: The cytochrome c reduction assay provides direct measurement of electron transport function. By comparing the rate of cytochrome c reduction between wild-type and mutant samples, researchers can quantify the functional impact of specific mutations.
-
Correlation with clinical phenotypes: The severity of functional defects can be correlated with clinical manifestations in patients carrying specific MT-CYB mutations, establishing genotype-phenotype relationships.
This comprehensive approach enables researchers to understand how genetic variations in MT-CYB impact both the structure and function of the ubiquinol-cytochrome c reductase complex, contributing to our understanding of mitochondrial diseases and potentially identifying therapeutic targets .
How can phylogenetic analysis of ubiquinol-cytochrome c reductase complex components be utilized in evolutionary biology research?
Natural variations in the sequence of MT-CYB (which encodes cytochrome b) have proven highly valuable for determining phylogenetic relationships between organisms. The ubiquinol-cytochrome c reductase complex, particularly its mitochondrially-encoded components, offers several advantages for evolutionary studies:
-
The MT-CYB gene has a relatively slow mutation rate compared to nuclear genes, making it suitable for studying relationships between closely related species.
-
As the only protein within complex III encoded by the mitochondrial genome, cytochrome b sequence analysis provides insights into the co-evolution of nuclear and mitochondrial genomes.
-
The functional constraints on this protein limit acceptable mutations, making changes that do occur particularly informative for evolutionary studies.
-
The universal presence of this complex across eukaryotes allows for broad comparative studies.
Researchers can utilize antibodies against conserved epitopes of the complex to study its structural conservation across species, complementing genetic analyses. Combining immunological detection with functional assays can reveal how evolutionary changes have affected both structure and function of this critical respiratory complex .
What methodological approaches can researchers use to study the assembly and stability of ubiquinol-cytochrome c reductase complex in various experimental conditions?
Studying the assembly and stability of the ubiquinol-cytochrome c reductase complex requires sophisticated methodological approaches:
| Method | Application | Expected Outcome |
|---|---|---|
| Blue Native PAGE | Separation of intact complexes | Visualization of assembled complexes and subcomplexes |
| Sucrose gradient ultracentrifugation | Isolation of complexes based on size/density | Purification of intact complexes for further analysis |
| Pulse-chase labeling | Monitoring assembly kinetics | Determination of assembly rate and intermediate formation |
| Crosslinking followed by mass spectrometry | Identifying protein-protein interactions | Mapping of subunit arrangements within the complex |
| Protease protection assays | Assessing stability and conformation | Identification of protected regions indicating stable interactions |
| Site-directed mutagenesis | Testing importance of specific residues | Determination of critical regions for assembly/stability |
These approaches can be combined with antibody-based detection methods to track specific subunits during assembly or in response to destabilizing conditions. For example, researchers can use antibodies against the 6.7 kDa subunit to monitor its incorporation into the complex under various experimental conditions or in the presence of assembly inhibitors .
How does the ubiquinol-cytochrome c reductase complex interact with other respiratory chain components in different cellular contexts?
The ubiquinol-cytochrome c reductase complex (Complex III) interacts with other respiratory chain components in a dynamic manner that can vary across cellular contexts. Understanding these interactions is crucial for comprehending mitochondrial function in different tissues and pathological states.
Key interactions include:
-
Complex III-cytochrome c interaction: The electron transfer from Complex III to cytochrome c is a critical step in the respiratory chain. This interaction can be studied using the cytochrome c reduction assay, which monitors electron transfer at 550 nm. Different cellular contexts may exhibit variations in the efficiency of this electron transfer, potentially due to differences in the expression or post-translational modifications of cytochrome c or Complex III components.
-
Supercomplex formation: Complex III associates with Complexes I and IV to form respirasomes or supercomplexes, which enhance electron transfer efficiency and reduce reactive oxygen species production. The composition and stability of these supercomplexes can vary between tissues and in response to metabolic conditions. Antibodies against specific subunits of Complex III can be used in co-immunoprecipitation experiments to study these interactions.
-
Interaction with CoQ pool: Complex III accepts electrons from the ubiquinol (reduced CoQ) pool, which serves as a mobile electron carrier. The accessibility and redox state of this pool can influence Complex III activity and can be tissue-specific due to variations in CoQ biosynthesis.
-
Membrane microdomain localization: The distribution of respiratory complexes within the inner mitochondrial membrane is not uniform, and their localization to specific microdomains can affect their interactions and function. Imaging techniques combined with antibody labeling can reveal these spatial relationships.
Research methodologies for studying these interactions include blue native PAGE, proximity labeling techniques, co-immunoprecipitation, and advanced imaging approaches like super-resolution microscopy .
